Skip to main content
METabolic EXplorer logo

METabolic EXplorer — Investor Relations & Filings

Ticker · METEX ISIN · FR0004177046 LEI · 969500VI1GSBPGD9B460 PA Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2018-04-30 Annual Report
Country FR France
Listing PA METEX

About METabolic EXplorer

https://www.metabolic-explorer.com/

METabolic EXplorer (METEX) is an industrial biotechnology company specializing in the development and industrialization of fermentation bioprocesses. The company produces functional ingredients and chemical intermediates from renewable, non-food raw materials, offering sustainable alternatives to petrochemical processes. Its portfolio is centered on three main product families: 1,3-propanediol (PDO) for cosmetics, liquid polymers, and textiles; butyric acid (BA) for animal nutrition and the flavors and fragrances market; and amino acids for animal feed. The company operates through its subsidiaries, METEX NØØVISTA, which manages the PDO and BA production, and METEX NØØVISTAGO, which focuses on amino acids and ingredients for animal nutrition.

Recent filings

Filing Released Lang Actions
RAPPORT FINANCIER ANNUEL 2017
Annual Report Classification · 100% confidence The document is titled 'RAPPORT FINANCIER ANNUEL 2017' (Annual Financial Report 2017) and contains comprehensive financial statements, management reports, audit reports, and governance information for the fiscal year ending December 31, 2017. It includes detailed consolidated financial data under IFRS and French accounting standards, fulfilling the criteria for an Annual Report (10-K equivalent in this context). FY 2017
2018-04-30 French
METabolic EXplorer : Mise à disposition du rapport financier annuel 2017
Report Publication Announcement Classification · 99% confidence The document is titled "METabolic EXplorer : Mise à disposition du rapport financier annuel 2017" (Making available of the 2017 annual financial report). It explicitly states that the company has made its 'rapport financier annuel au 31 décembre 2017' (annual financial report as of December 31, 2017) available to the public and filed it with the AMF (Autorité des marchés financiers). The content lists the components of this annual report (management report, annual accounts, auditor reports, etc.). Crucially, the document itself is an announcement *about* the availability of the report, not the full report itself. The document length is short (3087 characters). According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating a report has been published or made available should be classified as a Report Publication Announcement (RPA). Although the subject is the Annual Report (10-K equivalent in some jurisdictions), the document's function here is to announce its publication.
2018-04-30 French
Déclaration du nombre total d'Actions et Droits de Votes au capital social le 31/03/2018
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "Déclaration du nombre total d'Actions et Droits de Votes au capital social le 31/03/2018" (Declaration of the total number of Shares and Voting Rights in the share capital as of 03/31/2018) and explicitly references Article 223-16 of the AMF (Autorité des Marchés Financiers) general regulation. It provides a breakdown of total shares, theoretical voting rights, and shares deprived of voting rights (self-held shares). This content directly relates to official announcements regarding the total number of shares and voting rights outstanding, which is a specific regulatory disclosure often required periodically. Among the provided codes, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most appropriate fit for official disclosures concerning voting rights counts, even if it's not the result of a specific vote, but rather the total capital structure relevant to voting. It is not a full report (10-K, IR), an earnings release (ER), or a director's dealing (DIRS). Given the specific nature of reporting total voting rights, DVA is selected over the general RNS.
2018-04-30 French
Metabolic Explorer : Discontinuation of the Valchem project following the joint decision to defer the MPG production project.
Environmental & Social Information Classification · 99% confidence The document is a short press release dated April 18, 2018, announcing the discontinuation of the Valchem project following a joint decision regarding the MPG production project. It details operational and partnership updates, including the cessation of EU grant funding. This type of announcement, which communicates a significant business event or operational change outside of standard periodic financial reporting (like 10-K or IR), fits best under the general 'Regulatory Filings' category (RNS) as it is a material, non-financial disclosure. It is too specific for a general 'LTR' (Legal Proceedings) and does not relate to management changes (MANG), financing (CAP), or dividends (DIV). Given its nature as a specific corporate update/announcement, RNS is the most appropriate fallback.
2018-04-18 English
Metabolic Explorer : Arrêt du projet Valchem suite à la décision commune de reporter le projet de production de MPG.
Legal Proceedings Report Classification · 99% confidence The document is a press release dated April 18, 2018, announcing the termination of the Valchem project due to a bilateral decision to postpone the MPG production development. It details the cessation of EU funding (BBI-JU/Horizon 2020) related to this specific project and provides general company information about METabolic EXplorer (METEX). This type of announcement, which communicates a specific, non-periodic corporate event (like the termination of a joint venture or project), does not fit neatly into standard periodic reports (10-K, IR, ER) or specific corporate actions (DIV, CAP, M&A). Since it is a formal communication about a significant operational/project development that doesn't align with the other specific categories (like DIRS, DVA, DLST), the most appropriate classification is the general regulatory announcement fallback category, RNS (Regulatory Filings). The document length is short (3290 chars), but it is the primary announcement itself, not just a notice that a report is attached, thus ruling out RPA.
2018-04-18 French
Résiliation du contrat de liquidité et mise en œuvre d'un nouveau contrat
Transaction in Own Shares Classification · 95% confidence The document announces the termination of an existing liquidity contract and the implementation of a new liquidity contract with Kepler Cheuvreux, effective April 3, 2018. This action relates to the management of the company's stock liquidity, which is a financial/capital market activity. While it is a regulatory announcement, the specific nature of managing stock liquidity contracts (often related to market making or share stabilization) fits best under 'Capital/Financing Update' (CAP) or potentially 'Regulatory Filings' (RNS) if no better fit exists. However, since it directly concerns the capital structure management via market operations, 'CAP' is a strong candidate. Given the context of financial market operations and capital management, and since it is a specific announcement rather than a general regulatory filing fallback, I will classify it as a Capital/Financing Update (CAP). It is not an earnings release, dividend notice, or a report itself, but a specific corporate action related to financing/market support.
2018-04-05 French

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.